Quorum Sensing Inhibitors: An Alternative Strategy to Win the Battle against Multidrug-Resistant (MDR) Bacteria

Helal F Hetta1, Yasmin N Ramadan2, Zainab I Rashed2

  • 1Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.

PubMed

Insights

Antibiotic resistance is a growing global health threat. Quorum sensing inhibitors (QSIs) offer a promising non-antibiotic approach to combat multidrug-resistant bacteria by disrupting their communication and biofilm formation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Antibiotic resistance is a critical global health concern, leading to millions of deaths annually.
  • Biofilm formation by microbial communities contributes significantly to infectious diseases.
  • Multidrug-resistant (MDR) strains have emerged due to antibiotic overuse, necessitating alternative therapies.

Purpose of the Study:

  • To review quorum sensing (QS) inhibition as a novel strategy against bacterial infections.
  • To explore the mechanisms of QS and quorum quenching (QQ) in combating antibiotic resistance.
  • To highlight the potential of QS inhibitors (QSIs) as non-traditional therapeutic agents.

Main Methods:

  • Literature review focusing on quorum sensing mechanisms and inhibition strategies.
  • Analysis of QS-regulated processes, including virulence factor expression and biofilm formation.
  • Examination of QSIs and QQ enzymes as potential therapeutic interventions.

Main Results:

  • Quorum sensing (QS) is a cell-density-dependent communication system crucial for bacterial virulence and biofilm formation.
  • Inhibiting QS can prevent the expression of virulence factors and disrupt biofilm development.
  • QSIs and QQ enzymes effectively interfere with bacterial communication, offering an alternative to antibiotics.

Conclusions:

  • Quorum sensing inhibition presents a viable strategy to overcome antibiotic resistance.
  • Targeting bacterial communication pathways with QSIs is a promising approach for developing new anti-infective therapies.
  • Further research into QS inhibition mechanisms and agents is crucial for clinical application against resistant bacteria.

Related Concept Videos

Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
31.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Antibiotic Selection00:57

Antibiotic Selection

Overview
52.7K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.4K